Patents by Inventor Florian Wolschin

Florian Wolschin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ACE2 Fusion Proteins and Uses Thereof
    Publication number: 20240018499
    Abstract: The present invention relates to fusion proteins of ACE2 with IgG Fc and the medical use of these fusion proteins, in particular in the prevention or treatment of infections with coronaviruses such as SARS-CoV-2.
    Type: Application
    Filed: October 29, 2021
    Publication date: January 18, 2024
    Inventors: Alwin Reiter, Carsten Brockmeyer, Florian Wolschin
  • ACE2 fusion proteins and uses thereof
    Publication number: 20210363512
    Abstract: The present invention relates to fusion proteins of ACE2 with IgG Fc and the medical use of these fusion proteins, in particular in the prevention or treatment of infections with coronaviruses such as SARS-CoV-2.
    Type: Application
    Filed: May 21, 2021
    Publication date: November 25, 2021
    Inventors: Alwin Reiter, Carsten Brockmeyer, Florian Wolschin
  • Antibody preparation
    Patent number: 11021530
    Abstract: The present invention relates to the field of biotechnology, and in particular to the field of antibodies. Provided herein are novel methods for removing glycosylated antibody variants from an antibody preparation, an antibody preparation obtained by said method, and a pharmaceutical composition comprising the same.
    Type: Grant
    Filed: October 30, 2017
    Date of Patent: June 1, 2021
    Assignee: Hexal AG
    Inventors: Claudia Torella, Benjamin Hackner, Carsten Funke, Michael Otten, Christina Hildebrandt, Renate Lafuntal, Florian Wolschin
  • Antibody Preparation
    Publication number: 20200055923
    Abstract: The present invention relates to the field of biotechnology, and in particular to the field of antibodies. Provided herein are novel methods for removing glycosylated antibody variants from an antibody preparation, an antibody preparation obtained by said method, and a pharmaceutical composition comprising the same.
    Type: Application
    Filed: October 30, 2017
    Publication date: February 20, 2020
    Applicant: Hexal AG
    Inventors: Claudia Torella, Benjamin Hackner, Carsten Funke, Michael Otten, Christina Hildebrandt, Renate Lafuntal, Florian Wolschin